Abiopharma

New Form SCHEDULE 13G/A - MACROGENICS INC Filed: 2025-05-15 AccNo: 0001172661-25-002266 Size: 10 KB

New Form SCHEDULE 13G/A - Moleculin Biotech, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002265 Size: 10 KB

New Form SCHEDULE 13G/A - Kura Oncology, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002262 Size: 10 KB

New Form SCHEDULE 13G/A - IRONWOOD PHARMACEUTICALS INC Filed: 2025-05-15 AccNo: 0001172661-25-002261 Size: 10 KB

New Form SCHEDULE 13G/A - INTENSITY THERAPEUTICS, INC. Filed: 2025-05-15 AccNo: 0001172661-25-002259 Size: 10 KB

New Form SCHEDULE 13G/A - FIBROGEN INC Filed: 2025-05-15 AccNo: 0001172661-25-002255 Size: 10 KB

New Form SCHEDULE 13G - PDS Biotechnology Corp Filed: 2025-05-15 AccNo: 0001172661-25-002256 Size: 10 KB

New Form SCHEDULE 13G/A - Biofrontera Inc. Filed: 2025-05-15 AccNo: 0000935836-25-000371 Size: 6 KB

New Form SCHEDULE 13G/A - Enlivex Therapeutics Ltd. Filed: 2025-05-15 AccNo: 0001172661-25-002254 Size: 10 KB

New Form SCHEDULE 13G/A for Altamira Therapeutics

New Form SCHEDULE 13G/A - EKSO BIONICS HOLDINGS, INC. Filed: 2025-05-15 AccNo: 0001172661-25-002252 Size: 10 KB

New Form SCHEDULE 13G - Processa Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002253 Size: 10 KB

New Form SCHEDULE 13G/A - Dermata Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002251 Size: 10 KB

New Form SCHEDULE 13G/A - Altamira Therapeutics Ltd. Filed: 2025-05-15 AccNo: 0001172661-25-002248 Size: 10 KB

New Form SCHEDULE 13G/A - Cyclacel Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002246 Size: 10 KB